Tag: AFX2

CE mark reinstated for Endologix AFX and AFX2 systems

The CE mark for Endologix’ AFX and AFX2 endovascular abdominal aortic aneurysm systems has been reinstated, effective immediately.  The CE mark was temporarily suspended due...

Endologix resumes shipments of all sizes of AFX2 systems

Endologix has resumed shipments of all sizes of AFX2 endovascular abdominal aortic aneurysm systems. The large diameter sizes of AFX2 were placed on a temporary...

Endologix provides physicians with updated AFX information

Endologix has issued a letter to physicians with updated information about the AFX endovascular abdominal aortic aneurysm system. The voluntary letter, issued after discussions with...

Australian Therapeutic Goods Administration approves Endologix’ AFX2 bifurcated endograft system

The Australian Therapeutic Goods Administration (TGA) has approved Endologix’ AFX2 bifurcated endograft system for inclusion on the Australian Register of Therapeutic Goods. The TGA...